Shilajit and Antidepressants (Sertraline, Escitalopram)
Leila WehrhahnUpdated:Key points at a glance:
Shilajit is a natural, mineral-rich substance. There is a lack of robust clinical data on its use in combination with sertraline or escitalopram. Theoretical considerations focus on possible effects on hormones and interactions with metabolic pathways. Serious interactions have not been clearly documented. Product quality can vary considerably. It is advisable to use shilajit only after medical consultation, to start with a low dose, monitor closely, and choose products that have been independently tested. Certain groups of people may be advised to avoid it altogether.
Shilajit is a traditional, mineral-rich natural substance with a high proportion of fulvic and humic acids. On social media it is often associated with topics such as energy, libido and cognitive performance. At the same time, sertraline and escitalopram are among the most commonly prescribed SSRI antidepressants. There are currently no reliable clinical data on the combination of Shilajit + SSRIs; nonetheless, caution is advisable – particularly because of possible effects on hormone balance and potential metabolic interactions. (1)
More in-depth information on shilajit can be found here: effects, interactions and side effects.
There are no robust studies on the combination of Shilajit + SSRIs. Caution is advisable because of possible hormonal and metabolic effects.
How might shilajit interact with sertraline/escitalopram?
1) Hormonal balance
A randomised, controlled study in men reported that purified shilajit taken over 90 days was associated with a significant increase in total and free testosterone and DHEAS levels (250 mg twice daily). (2) Changes in hormone levels may influence mood, drive and sleep – factors that are also relevant when taking antidepressants. This does not mean that shilajit “cancels out” the effect of SSRIs; however, it may contribute to changes in individual symptom patterns (e.g. inner restlessness vs. motivation).
2) Pharmacokinetics (metabolism)
Sertraline is metabolised by several CYP enzymes (in particular CYP2C19, CYP2B6, CYP3A4; to some extent CYP2D6). (5) For escitalopram, CYP2C19 is the most important enzyme, with contributions from CYP3A4 and CYP2D6. (4) Genetic differences in CYP2C19/CYP2B6 can influence SSRI levels and tolerability; CPIC provides dosing recommendations in this context. (3)
For shilajit, there are no reliable human data showing that it inhibits or induces these enzymes in a clinically relevant way. Because of its complex composition (fulvic acids, dibenzo-α-pyrones, trace elements), theoretical interactions are conceivable, but they have not been demonstrated so far. (1)
SSRIs are metabolised via CYP enzymes. For shilajit, there is no evidence of clinically relevant CYP inhibition or induction.

Shilajit Capsules
Clinical evidence: What does the research say about the combination?
There are no controlled studies and no robust case series on the concurrent use of shilajit with sertraline or escitalopram. (1) Existing shilajit studies focus on other endpoints (for example, testosterone levels or connective-tissue markers) and do not allow firm conclusions about interaction with SSRIs. (2)
On the SSRI side, the data are relatively solid: the metabolism of sertraline/escitalopram is well characterised and pharmacogenetic guidelines (CPIC) are available. (3–5) Another uncertainty factor is product quality: reviews describe variability and possible contamination with heavy metals for some shilajit products. This does not apply to all products, but it does highlight the importance of tested quality. (6)
Risk assessment
Severity
Based on current evidence, the interaction risk with shilajit + sertraline/escitalopram is generally considered low to moderate – mainly on theoretical grounds (hormone balance; potential overlaps in metabolism) and depending on individual sensitivity and product quality. Well-documented, severe interactions (such as serotonin syndrome) have not been reported for shilajit. (1,3–5)
Probability
Unknown. There is no systematic evidence of frequent problems with this combination. The likelihood may increase with: high doses of shilajit, genetically reduced SSRI metabolism (CYP2C19/CYP2B6 poor metabolisers), liver disease, and when using contaminated or mislabelled products. (3–6)
No confirmed evidence of harm, but theoretical risks exist. Product quality and individual factors are key.
🧪 Shilajit Compatibility Check
Find out if there are any known risk factors that could contraindicate taking Shilajit.
Question 1 of 8
Practical recommendations for safe use
- Discuss with a doctor: Speak to your prescribing doctor in advance – especially if there are changes to your sertraline/escitalopram dose, known liver problems or additional medicines. (3–5)
- Start low, increase slowly: If you decide to use shilajit at all, start with the lowest commonly used dose and monitor effects and tolerability over 2–4 weeks (restlessness, sleep, gastrointestinal symptoms, headaches). Record any changes. (1,2)
- Dose spacing: Taking the doses at different times of day (e.g. SSRI in the morning, shilajit at midday/evening) may help to reduce gastrointestinal discomfort. However, potential metabolic interactions via CYP enzymes are not reliably prevented by this. (3–5)
- Monitoring while on SSRIs: Pay attention to new or noticeably increased SSRI-typical side effects (such as nausea, inner restlessness, tremor). If symptoms clearly worsen, stop taking shilajit and seek medical advice. (3–5)
- Quality over quantity: Use only products with evidence of purification/standardisation and independent testing for contaminants (e.g. heavy metals). Large quality differences between products have been described. (6)
- Avoid in certain groups: Pregnant or breastfeeding individuals, people with severe liver or kidney disease, or diagnosed haemochromatosis are generally advised to avoid shilajit. (1,6)
- Clarify your goals and consider alternatives: If your focus is energy or stress resilience, discuss evidence-based options (such as sleep hygiene, physical activity, psychological support, and, where appropriate, other, better-characterised supplements) with a healthcare professional.
Further context on possible effects can be found under shilajit effects, and information on risks under shilajit side effects and shilajit interactions.
Conclusion
There are no robust study data on the combination of shilajit + sertraline/escitalopram. Hormonal effects and overlapping metabolic pathways are theoretically relevant, but clear clinical signals are lacking. Anyone considering shilajit while taking SSRIs should do so only after medical advice, with a low dose, careful self-observation and by using products with tested quality. (1–6)
Medical disclaimer
Important note: This information does not replace professional medical advice. Always consult your doctor or pharmacist before taking shilajit. Every individual may respond differently to food supplements and medicines.
